# Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

> **NCT06800885** · — · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 5000 (actual)

## Conditions studied

- Influenza Immunization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06800885
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-22
- **Primary completion:** 2026-02-22
- **Final completion:** 2026-02-22
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06800885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06800885, "Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06800885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*